NCT01579032

Brief Summary

The aims of the presented study are as follows:

  1. 1.To evaluate the endothelial function and arterial stiffness in a large cohort of prevalent CKD patients by means of non-invasive applantion tonometry.
  2. 2.To evaluate the association between the serum levels of the representatives of the various classes of uremic toxins and markers of endothelial function and arterial stiffness.
  3. 3.To evaluate the association between markers of inflammation and oxidative stress and markers of endothelial function and arterial stiffness.
  4. 4.To evaluate the association between echocardiographic parameters and markers of arterial stiffness

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2004

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 17, 2012

Completed
Last Updated

October 17, 2018

Status Verified

October 1, 2018

Enrollment Period

8 years

First QC Date

April 13, 2012

Last Update Submit

October 15, 2018

Conditions

Keywords

CKD,

Study Arms (1)

CKD patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

CKD patients

You may qualify if:

  • Age: 18-60
  • Chronic kidney disease: according to the K-DOQI guidelines ( kidney damage ≥ three months, as defined by structural or functional abnormalities of the kidney, with or without decreased GFR, manifest by either: pathological abnormalities; or markers of kidney damage, including damage in the composition of blood or urine test, or abnormalities in imaging tests; GFR\< 60 ml/min/1.73m² for ≥ three months, with or without kidney damage)
  • Written informed consent

You may not qualify if:

  • major illnesses( life expectancy of \< 1 year)
  • history of atrial fibrillation
  • history of myocardial infarction, unstable angina, congestive heart failure, peripheral vascular diasease ,cerebrovascular disease, diabetes
  • (nonechogenic)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospitals

Leuven, 3000, Belgium

Location

UZ Leuven

Leuven, 3000, Belgium

Location

MeSH Terms

Conditions

Kidney Failure, ChronicHypertrophy, Left Ventricular

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsCardiomegalyHeart DiseasesCardiovascular DiseasesHypertrophyPathological Conditions, Anatomical

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2012

First Posted

April 17, 2012

Study Start

January 1, 2004

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

October 17, 2018

Record last verified: 2018-10

Locations